On the therapeutic use of nucleosides and the penetrability of phosphorylated compounds.
D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000494:pharmacology; D006152:Cyclic GMP / Q000494:pharmacology; D003561:Cytarabine / Q000627:therapeutic use; D009696:Nucleic Acids / Q000378:metabolism; D009705:Nucleosides / Q000627:therapeutic use*; D009711:Nucleotides / Q000378:metabolism; D009712:Nucleotides, Cyclic / Q000378:metabolism; D009940:Organoids / Q000378:metabolism; D009943:Organophosphorus Compounds / Q000378:metabolism*; D013431:Sulfates / Q000494:pharmacology
D058892:Adenosine Deaminase Inhibitors; D009696:Nucleic Acids; D009705:Nucleosides; D009711:Nucleotides; D009712:Nucleotides, Cyclic; D009943:Organophosphorus Compounds; D013431:Sulfates; D003561:Cytarabine; D000242:Cyclic AMP; D006152:Cyclic GMP